MEETINGS & COURSES
Find a meeting
 FEATURED MEETINGS
  Rome 2010
  Kiawah Eye 2010
  OSN New York 2010
  Hawaiian Eye 2011
  Retina 2011
 
Breaking Influenza
A (H1N1) Updates
GLAUCOMA
Posted on the OSN SuperSite April 11, 2008
Hi-Tech Pharmacal receives tentative FDA approval for generic combination glaucoma drop
Submit a Comment Submit a Comment Print  Print Email this page to a friend  E-mail

AMITYVILLE, N.Y. — Hi-Tech Pharmacal's abbreviated new drug application for dorzolamide hydrochloride-timolol maleate ophthalmic solution has received tentative approval from the U.S. Food and Drug Administration, the company announced in a press release.

Story continues below↓

ADVERTISEMENT

Hi-Tech's dorzolamide hydrochloride with timolol maleate ophthalmic solution is the generic equivalent of Merck's Cosopt and is indicated for treating glaucoma.

Hi-Tech expects to have 180 days of exclusive marketing rights for the generic drug combination and plans to begin product marketing pending the completion of Merck's pediatric exclusivity period in October 2008, the release said.

The OSN SuperSite is intended for physician use and all comments will be posted at the discretion of the editors. We reserve the right not to post any comments with unsolicited information about medical devices or other products. At no time will the OSN SuperSite be used for medical advice to patients.

There are no comments for this article. Be the first to comment.

Your comment

Name:
Comments:
SEE ALSO
Rotational lamellar scleral flap technique useful for bleb leak
OCULAR SURGERY NEWS U.S. EDITION February 10, 2010
Limbal-based trabeculectomy with anchor sutures has high survival rate
Posted on the OSN SuperSite February 8, 2010
SAP shows earlier conversion to glaucoma than SWAP in some cases
Posted on the OSN SuperSite February 3, 2010
MULTIMEDIA
Ozurdex injection technique
Ozurdex injection technique

Submitted by: Allergan; Sunil Gupta, MD (2/4/2010).

more

COVER STORIES
Endothelial keratoplasty challenges the primacy of full-thickness transplantation
Corneal transplantation has long been the preferred treatment for pathologies that respond poorly to topical medications or implants.
more